Clinical cancer epidemiology: From prevention to treatment and patient care

Register for this five-day blended course (spread across June to December 2023) to develop your understanding of clinical cancer epidemiology and how it can provide a methodology for researching prevention, early diagnosis and detection, treatment outcomes, and living with and beyond cancer.
Write your awesome label here.

4 virtual days and 1 face-to-face spread across June to December

For PhD students and healthcare staff in training roles

For all other delegates

Organising team

Mieke Van Hemelrijck
Professor in Cancer Epidemiology
mieke.vanhemelrijck@kcl.ac.uk

Prof Van Hemelrijck studied for an MSc in Biomedical Sciences (2001-2005) and an MSc in Statistical Analysis (2005-2006) at Ghent University, Belgium. While doing so, she became engaged in epidemiology research in the field of urology. She continued her epidemiological training by spending two years at the Harvard School of Public Health (2006-2008), where she obtained an MSc in Population & International Health, staying focused on urological research. From 2008-2010, she worked with Professor Holmberg at King’s College London and obtained a PhD in Cancer Epidemiology. In 2012, she was appointed as a Lecturer in Cancer Epidemiology at King’s College London. She leads the Translational Oncology and Urology Research (TOUR) Team in the School of Cancer & Pharmaceutical Sciences and became a Professor in late 2020. 
Martin Eklund
Professor of Epidemiology
 martin.eklund@ki.se 

Martin is based at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet (KI), where his research focuses on reducing the mortality of breast and prostate cancer through the use of individualised prevention, diagnostics, and treatment, based on the combined use of biomarkers, genomics, imaging, machine learning, and clinical translation via trials.

Expert speakers

Each day we will bring in international leaders from the field, with practical experience of using epidemiology to improve cancer patients’ outcomes and experiences – including patient advocates. Speakers include:

Austria: Prof Bernhard Holzner (University of Innsbruck)
Belgium: Dr Bram De Laere (Ghent University)
Sweden: Prof Per Hall (Karolinska Institute); Dr Linus Jonsson (Karolinska Institute); Dr Mattias Rantalainen (Karolinska Institute)
Switzerland: Prof Sabine Rohrmann (University of Zurich)
The Netherlands: Prof Lonneke van de Poll-Franse (National Cancer Institute Amsterdam); Prof Monique Roobol (Erasmus University Rotterdam); Prof Winette Van der Graaf (National Cancer Institute Amsterdam and President of EORTC)
UK: Prof Peter Sasieni, Dr Jo Waller, Dr Ajay Aggarwal, Dr Elizabeth Davies, Dr Louis Fox and Dr Jiayao Lei (King’s College London); Dr Steven MacLennan (University of Aberdeen); Prof Karen Brown (Leicester University)
Patient Advocates: Dr Rachel Giles (International Kidney Cancer Coalition) and Dr Lydia Makaroff (World Bladder Cancer Patient Coalition)

Why should I take this course?

Since the Covid-19 pandemic, epidemiology has become a much better known discipline. However, in clinical cancer research, we need epidemiology throughout the entire patient pathway.


Introduces the importance of clinical cancer epidemiology while keeping the clinical impact of the discipline at the centre.
Clinical guest lectures highlighting how clinical epidemiological methodology has led to studies of important clinical impact for people with cancer. 

What's included

Discussions on different components of clinical epidemiology and how they interact with various other disciplines.
Opportunities to present your research ideas and get feedback from experts in the field.

Programme

Five days of live events: four virtual and one face-to-face. Each event runs from 09:00 to 16:00.

The day 5 event is hybrid – see below for details.

Day 1: Cancer prevention | Friday 16 June 2023 | Virtual

9:00 – 9:30: Introduction
Prof Martin Eklund, Karolinska Institute
9:30 – 10:30: Clinical Guest Lecture: Large cohort and case-control studies to investigate risk factors for cancer
Prof Sabine Rohrmann, University of Zurich
10:45 – 12:00: Introduction to Cancer Epidemiology
Prof Mieke Van Hemelrijck, King’s College London
13:00 – 14:15: Chemoprevention and lifestyle interventions
Prof Karen Brown, Leicester University
14:30 – 15:45: Health inequalities
Speaker to be confirmed
15:45 – 16:00: Summary
Prof Mieke Van Hemelrijck, King’s College London

Day 2: Early detection and screening | Thursday 7 September 2023 | Virtual

9:00 – 9:30: Introduction and recap
Prof Mieke Van Hemelrijck, King’s College London
9:30 – 10:30: Clinical Guest Lecture: Cervical cancer screening
Prof Peter Sasieni, King’s College London
10:45 – 12:00: Introduction to screening
Dr Jiayao Lei, KCL
13:00 – 14:15: Molecular epidemiology – omics and risk stratification
Prof Per Hall, Karolinska Institute
14:30 – 15:45: Behavioural sciences
Dr Jo Waller, King’s College London
15:45 – 16:00: Summary
Prof Martin Eklund, Karolinska Institute

Day 3: Treatment | Wednesday 11 October 2023 | Virtual

9:00 – 9:30: Introduction and recap
Prof Martin Eklund, Karolinska Institute
9:30 – 10:30: Clinical Guest Lecture: From surveillance, to surgery, radiotherapy, and systemic anti-cancer treatments – what have we learned in prostate cancer?
Speaker to be confirmed
10:45 – 12:00: The need for core outcome sets
Dr Steven MacLennan, University of Aberdeen
13:00 – 14:15: Randomised controlled trials or real world evidence
Prof Winette Van der Graaf, Netherlands Cancer Institute (NKI) and European Organisation for Research and Treatment of Cancer (EORTC)
14:30 – 15:45: Personalised medicine and artificial intelligence
Prof Martin Eklund, Karolinska Institute
15:45 – 16:00: Summary
Prof Mieke Van Hemelrijck, King’s College London

Day 4: Living with and beyond cancer | Tuesday 7 November 2023 | Virtual

9:00 – 9:30: Introduction and recap
Prof Mieke Van Hemelrijck, King’s College London
9:30 – 10:30: Clinical Guest Lecture: Cancer survivorship: the short- and long-term physical and psychosocial consequences of cancer and its treatment 
Prof Lonneke van de Poll-Franse, NKI
10:45 – 12:00: Mixed methods
Dr Louis Fox, King’s College London
13:00 – 14:15: Quality of Life research for cancer patients
Prof Bernhard Holzner, University of Innsbruck
14:30 – 15:45: The role of health economics
Dr Linus Jonsson, Karolinska Institute
15:45 – 16:00: Summary
Prof Martin Eklund, Karolinska Institute

Day 5: Clinical cancer epidemiology across the patient’s pathway | 8 December 2023 | Hybrid (face-to-face or remote)

This hybrid event will be hosted at either the King's College London Guy's Campus or St. Thomas' Hospital (room tbc), with the option to join remotely.

9:00 – 9:30: Introduction and recap
Prof Martin Eklund, Karolinska Institute
9:30 – 10:30: Clinical Guest Lecture: Linking epidemiology and shared treatment decision-making in the cancer pathway
Prof Monique Roobol, Erasmus University
10:45 – 11:45: The value of big data
Dr Mattias Rantalainen, KI
12:45 – 14:00: The importance of patient and public involvement and engagement
Dr Rachel Giles, International Kidney Cancer Coalition and Dr Lydia Makaroff, World Bladder Cancer Patient Coalition
14:15 – 16:15: Poster presentations and summary

Learning objectives

By the end of the course, learners should be able to:
Describe the concepts, technologies and opportunities underlying clinical cancer epidemiology research
Describe the main approaches for linking clinical epidemiology with other disciplines to improve clinical impact
Explain current clinical applications and future perspectives of clinical cancer epidemiology
Explain why multidisciplinary approaches to clinical cancer epidemiology are necessary
Outline the strengths and limitations of different epidemiologic study designs

Ready to book?

We'd love to see you at the event!
5
DAYS
£150
FOR PHD STUDENTS and healthcare staff in training roles
£300
FOR ALL OTHER DELEGATES